Next Quarterly Earnings
Thursday, November 5, 2026
CW 45
After-Hours
In 70 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Adaptive Biotechnologies
Adaptive Biotechnologies, headquartered in the US, is a pioneer in decoding the adaptive immune response. The company develops and markets innovative diagnostic and therapeutic solutions based on deep analysis of antibodies and T-cell receptors, revolutionizing medical research and clinical applications in oncology, autoimmune diseases, and infectious diseases.
Frequently asked questions
When will Adaptive Biotechnologies report its next quarterly earnings?
Adaptive Biotechnologies is scheduled to report its next quarterly earnings on 11/05/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did Adaptive Biotechnologies last report quarterly earnings?
Adaptive Biotechnologies last reported quarterly earnings on 7/29/2026 (Q2 2026). Earnings per share (EPS) came in at -0.25 USD.
How does Adaptive Biotechnologies stock react to earnings?
Across its last 4 earnings reports, Adaptive Biotechnologies stock moved by ±5.9% on average the following day. The largest reaction was -11.5% on 11/05/2025; 1 of 4 reactions were positive.
How often has Adaptive Biotechnologies beaten expectations?
Adaptive Biotechnologies has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).
How do I add the Adaptive Biotechnologies earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±5.9%
Avg. next-day move
-11.5%
Largest move (11/05/2025)
25%
Share of positive reactions
±7.6%
Avg. move after 7 days
Basis: price reactions to the last 4 report dates (close to close).
Estimates vs. results
2/3
Quarters above estimates
66.7%
Beat rate
-5.7%
Avg. EPS surprise
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Adaptive Biotechnologies
Country
🇺🇸
More Financial Information